Current indications for acid suppressants in Helicobacter pylori -negative ulcer disease

This publication has 34 references indexed in Scilit:

• Helicobacter Pylori Infection Rates in Duodenal Ulcer Patients in The United States May Be Lower Than Previously Estimated
  American Journal of Gastroenterology, 1999
• H. pylori-negative duodenal ulcer prevalence and causes in 774 patients.
  Digestive Diseases and Sciences, 1999
• Low prevalence of Helicobacter pylori in an Australian duodenal ulcer population: NSAIDitis or the effect often years of H. pylori treatment?
  Australian and New Zealand Journal of Medicine, 1998
• Prevalence of Helicobacter pylori in Peptic Ulcer Patients in Greater Rochester, NY: Is Empirical Triple Therapy Justified?
  American Journal of Gastroenterology, 1998
• Where have all the Helicobacter gone? etiologic factors in patients with duodenal ulcers (DU) presenting to a University hospital
  Gastrointestinal Endoscopy, 1997
• Ranitidine bismuth citrate plus clarithromycin is effective for healing duodenal ulcers, eradicating H. pylori and reducing ulcer recurrence. RBC H. pylori Study Group [see comments]
  Alimentary Pharmacology & Therapeutics, 1996
• Ulcer Site and Complications: Relation to Helicobacter pylori Infection and NSAID Use
  Endoscopy, 1996
• Helicobacter pylori-Negative Duodenal and Pyloric Ulcer: Role of NSAIDs
  Digestion, 1996
• Acute perforated duodenal ulcer is not associated with Helicobacter pylori infection.
  Gut, 1993
• A study of the pathogenesis of Helicobacter pylori negative chronic duodenal ulceration.
  Gut, 1993